Dr. John Allen Piede, MD
- Medicare services, 2024
- 78,699
- Medicare patients, 2024
- 376
- Part D claims, 2024
- 1,849
- MIPS score, 2024
- 88
- Hospital affiliations
- 2
- Practice address
- 500 Office Park Dr, Mountain Brk, AL 35223
- Practice phone
- Call (205) 870-4783
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Birmingham Hematology Oncology Assoc
Mountain Brk, Alabama
Find Dr. Piede's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John Allen Piede is a hematologist and oncologist in Mountain Brk, Alabama
Dr. Piede practices at Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama.
Dr. Piede's NPI, 1972782548, was assigned on October 30, 2007. Dr. Piede graduated from Medical College of Georgia School of Medicine in 2006. Dr. Piede holds Alabama license 32392.
- NPI
- 1972782548NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3971654427
- NPI enumeration date
- October 30, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (205) 870-4783
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. John Allen Piede practices at Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama
Dr. Piede's primary practice is Birmingham Hematology Oncology Assoc, at 500 Office Park Dr, Mountain Brk, AL 35223 in Jefferson County. The practice phone is (205) 870-4783.
- Birmingham Hematology Oncology Assoc500 Office Park Dr, Mountain Brk, AL 35223 · Jefferson CountyPhone(205) 870-4783
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. John Allen Piede is affiliated with 4 sites of care and 1 medical group
Dr. Piede's primary practice is Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama. Dr. Piede is also affiliated with Grandview Medical Center. The medical group on file is Alabama Oncology. Dmand AI also links Dr. Piede to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. John Allen Piede's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Piede practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Birmingham Hematology Oncology Assoc | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John Allen Piede is one of 169 hematologists and oncologists in Alabama
Hematology and oncology is Dr. Piede's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Piede is licensed in Alabama.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
Hematologists and oncologists near Dr. Piede
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John Allen Piede billed Medicare for 78,699 services in 2024
CMS data shows 78,699 Medicare services from Dr. Piede across 29 procedure codes in 2024, for 376 Medicare patients. Medicare paid $1,374,064 for them. Every service was in an office.
Dr. Piede's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 34,0792024: 37,99711%
- Other services
- 2023: 36,2102024: 37,0662%
- Tests and treatments
- 2023: 1,8892024: 2,0096%
- Surgery
- 2023: 8282024: 8614%
- Office and hospital visits
- 2023: 8762024: 76613%
- Lab and pathology
- 2023: 252024: 0100%
Dr. Piede compared with the Alabama median for hematologists and oncologists, 2024
- Dr. Piede
- Alabama median
- Medicare services
- 78,699vs 1,22464.3 times
- Medicare patients
- 376vs 28233% above
- Part D claims
- 1,591vs 84688% above
Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.
Dr. Piede's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Piede?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Piede and other hematologists and oncologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John Allen Piede treated 376 Medicare patients in 2024, average age 75
CMS counts 376 Medicare patients who saw Dr. Piede in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Piede's median patient age at 69, with 71% women.
Dr. Piede's Medicare patients by age, 2024
Dr. Piede's Medicare patients by sex, 2024
- Women23663%
- Men14037%
Chronic conditions among Dr. Piede's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis56%
- Cancer53%
- Chronic kidney disease34%
- Diabetes34%
- Mood disorders29%
- Anxiety26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Piede's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women71%
- Men29%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. John Allen Piede wrote 1,849 Medicare Part D claims in 2024
In 2024, Dr. Piede wrote 1,849 Medicare Part D claims for 282 patients. 75% of them were for generic drugs. CMS names the drug for 1,591 of them, across 43 drugs with 11 or more claims each, at $3,656,000 in total drug cost. In 2023, CMS named 1,662 claims across 42 drugs.
Dr. Piede's Part D claims by kind of drug, 2024
- Generic1,388 claims75%
- Brand-name and other461 claims25%
Dr. Piede's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Piede's Part D claims, 2024
- Opioids9%164 of 1,849 claims
- Antibiotics2%43 of 1,849 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,6622024: 1,5914%
Drugs named by CMS: 43 in 2024, 42 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. John Allen Piede scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Piede for performance year 2024, reported as part of a group. Dr. Piede accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Piede's MIPS scores, performance year 2024
- 88of 100Final score
- 79.4of 100Quality
- 92of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John Allen Piede received $11,163 in industry payments from 2016 to 2025
CMS Open Payments shows 721 general payments to Dr. Piede from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,641.
General payments to Dr. Piede by program year, 2016 to 2025
General payments to Dr. Piede by kind, 2016 to 2025
- Food and beverage$10,99298%
- Education$1712%
Companies that paid Dr. Piede the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John Allen Piede graduated from Medical College of Georgia School of Medicine
Dr. Piede graduated from Medical College of Georgia School of Medicine in 2006.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. John Allen Piede's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John Allen Piede
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John Allen Piede's NPI number?
Dr. John Allen Piede's NPI number is 1972782548. It was assigned on October 30, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. John Allen Piede?
Dr. John Allen Piede is a hematologist and oncologist in Mountain Brk, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. John Allen Piede practice?
Dr. Piede practices at 500 Office Park Dr, Mountain Brk, AL 35223. Dr. Piede's primary practice is Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama. Dmand AI also links Dr. Piede to 1 hospital and 1 group practice or clinic.
What is Dr. John Allen Piede's office phone number?
The practice phone on file for Dr. Piede is (205) 870-4783.
What is Dr. John Allen Piede's medical license number?
Dr. Piede holds Alabama license 32392.
Which hospitals is Dr. John Allen Piede affiliated with?
Dr. Piede is affiliated with Grandview Medical Center. Dmand AI links Dr. Piede to 1 more hospital.
What medical group is Dr. John Allen Piede part of?
Dr. Piede is linked to Alabama Oncology.
Does Dr. John Allen Piede accept Medicare?
Yes. CMS data shows Dr. Piede billed Medicare for 78,699 services in 2024, and Dr. Piede accepts Medicare assignment.
What is Dr. John Allen Piede's MIPS score?
Dr. Piede's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. John Allen Piede see?
CMS counts 376 Medicare patients who saw Dr. Piede in 2024, with an average age of 75.
Show 5 more questionsShow fewer questions
What services does Dr. John Allen Piede bill to Medicare?
In 2024, Dr. Piede's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J9271) and injected or infused drug (J0897).
Where did Dr. John Allen Piede go to medical school?
Dr. Piede graduated from Medical College of Georgia School of Medicine in 2006.
What drugs does Dr. John Allen Piede prescribe most?
In 2024 Medicare Part D data, Dr. Piede's most prescribed drugs by claims were Letrozole, Eliquis and Hydroxyurea.
Has Dr. John Allen Piede received payments from drug or device companies?
CMS Open Payments shows $11,163 in general payments to Dr. Piede from 65 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. John Allen Piede been practicing?
Dr. Piede graduated from medical school in 2006, 20 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card